Physician profile
Christina E Gutierrez
NPI 1568487502
$9,703.74
in general payments reported to CMS, 2019-2025
12 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $199 · 2021: $17.27 · 2022: $358 · 2023: $8,552 · 2024: $29.65 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,500 · Travel and Lodging: $707 · Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,500.00 |
| Travel and Lodging | $707.40 |
| Food and Beverage | $547.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,345.73 | 2023-2024 | Davinci Xi, Da Vinci Sp, Da Vinci Surgical System |
| Abbvie INC. | $250.58 | 2019-2022 | |
| Acessa Health INC. | $176.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $176.40 | 2019 | |
| Medtronic, INC. | $149.93 | 2025 | Signia |
| Coopersurgical, INC. | $133.75 | 2023-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Hologic Sales and Service, LLC | $133.50 | 2019-2022 | |
| Davol INC. | $125.65 | 2023 | Arista Ah Flexitip |
| Myovant Sciences INC. | $103.82 | 2022 | |
| Gynesonics, INC. | $74.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.27 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.